TITLE

Bevantolol Hydrochloride -- Preclinical Pharmacologic Profile

AUTHOR(S)
Kaplan, Harvey R.
PUB. DATE
March 1986
SOURCE
Angiology;Mar1986 Part 2, Vol. 37 Issue 3, p254
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Bevantolol hydrochloride, a beta adrenoceptor antagonist, can be categorized using conventional schemes as being cardioselective, devoid of intrinsic sympathomimetic activity and having weak membrane-stabilizing and local anesthetic properties. The cardioselectivity of bevantolol was conferred by the incorporation of a 3,4-dimethoxyphenyl moiety into the terminal amino portion of the molecule. This portion of the molecule also appears to account for bevantolol's in vitro binding affinity at alpha-adrenoceptor sites; the in vivo significance of which remains unclear. In the various cardiovascular disease-state models, bevantolol's profile differed from that of propranolol, i.e., there was no initial pressor response in spontaneously hypertensive or renal hypertensive rats. In a myocardial ischemia model, bevantolol, unlike propranolol, increased contractile function in the ischemic myocardium. A ring hydroxylated urinary metabolite, which occured only in trace amounts in human urine, had an interesting profile when studied in animals at pharmacologic doses. It ranked high in cardioselectivity (like bevantolol), but unlike bevantolol showed significant intrinsic beta sympathomimetic activity. The clinical significance of this metabolite, if any, remains to be established. Collectively the preclinical profile of bevantolol showed it to have an interesting profile for a beta adrenoceptor antagonist in a variety of pharmacologic test systems.
ACCESSION #
16365119

 

Related Articles

  • Genetics and cardiovascular risk. Day, Ian N M; Wilson, David I // BMJ: British Medical Journal (International Edition);12/15/2001, Vol. 323 Issue 7326, p1409 

    Presents a review that describes genes that are known to have an important impact on the development of cardiovascular disease and discusses how their identification may improve risk management. Variations of genes and how they affect blood cholesterol concentrations; Way that genetics and...

  • A nationwide population screening program for diabetes in Brazil. Nucci, Luciana B.; Toscano, Cristiana M.; Maia, Ana Lourdes M.; Fonseca, Cláudio D.; Britto, Maria Moema B.; Duncan, Bruce B.; Schmidt, Maria Inês // Revista Panamericana de Salud Publica;Nov2004, Vol. 16 Issue 5, p320 

    Objectives. In 2001, persons throughout Brazil who were 40 years old or older were invited to participate in community screening for diabetes as part of the Brazilian Ministry of Health's Plan for the Reorganization of Care for Arterial Hypertension and Diabetes Mellitus. This report describes...

  • Journal watch.  // Pulse;11/1/2004, Vol. 64 Issue 43, p14 

    Presents several abstracts of the "Journal of Human Hypertension 2004." Control of hypertension in high risk patients; Connection of traffic exposure and heart attacks; Understanding of diabetes information by diabetics.

  • Enoxaparin sodium.  // Reactions Weekly;12/1/2007, Issue 1180, p14 

    The article describes the case of a 55-year-old patient who developed skin and mucosal ulcers that were associated with heparin-induced thrombocytopenia and thrombosis syndrome. The patient, who had a history of grade IV peripheral arterial occlusive disorders, had received perioperative...

  • Rapid Reduction of Severe Asymptomatic Hypertension: A Prospective, Controlled Trial.  // JAMA: Journal of the American Medical Association;2/23/90, Vol. 263 Issue 8, p1078 

    Discusses the abstract of a research study concerning the rapid reduction of severe asymptomatic hypertension, conducted by Kathleen R. Zeller and colleagues.

  • Training for skeletal muscle capillarization: a Janus-faced role of exercise intensity? Gliemann, Lasse // European Journal of Applied Physiology;Aug2016, Vol. 116 Issue 8, p1443 

    An introduction is presented which discusses various reports published within the issue on topics including exercise pulmonary hypertension, blood circulation disorders and cardiovascular diseases.

  • making sense of the new blood pressure guidelines. Martin, Adam // Health (Time Inc. Health);Sep2003, Vol. 17 Issue 7, p65 

    Looks at the changes made to the federal guidelines on prehypertensive people in the U.S. People who are considered prehypertensive; Reason for the changes in the guidelines; Advice for prehypertensive people.

  • NICE signals significant changes in BP guidance.  // Pulse;11/5/2005, Vol. 65 Issue 43, p4 

    Reports on the study which found that the ASCOT trial is likely to have a significant impact on new NICE and British Hypertension Society guidelines for hypertension in Great Britain. Confirmation of the need for a wider evaluation of hypertension guidance; Improvement of the first-line therapy;...

  • Morphological assessment of the cerebroprotective action of lanthanum acetate in chronic cerebral ischemia in rats. S. Gulyaev; I. Ubasheev; N. Kozhevnikova // Neuroscience & Behavioral Physiology;Sep2008, Vol. 38 Issue 7, p747 

    Abstract  The aim of the present work was to perform a morphological assessment of the cerebroprotective action of lanthanum acetate in chronic cerebral ischemia in rats. Chronic ischemia was produced in Wistar rats (weighing 160–180 g) by ligation of both common...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics